Phathom Pharmaceuticals (PHAT) PT Raised to $29 at Cantor Fitzgerald
Tweet
Share
E-mail
Get Alerts PHAT Hot Sheet
Price: $9.17 +7.76%
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Cantor Fitzgerald analyst Kristen Kluska raised the price target on Phathom Pharmaceuticals (NASDAQ: PHAT) to $29.00 (from $23.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- JPMorgan Starts Neway Valve Suzhou Co Ltd (603699:CH) at Overweight
- UBS Downgrades Borouge PLC (BOROUGE:UH) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Cantor Fitzgerald, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
